Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bei Chen

Showing results (601-610 of 633) with videos related to

Pageof 64
Sort By:
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
JAMA Oncology|July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.
The American Journal of Surgical Pathology|October 5, 2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneyLisha Wang, Yuping Zhang, Ying-Bei Chen, et al.
Leukemia|November 9, 2022
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphomaXi-Ya Li, Ji-Chuan Wu, Ping Liu, et al.
Nature Medicine|June 8, 2010
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanomaNallasivam Palanisamy, Bushra Ateeq, Shanker Kalyana-Sundaram, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary TractRayan Rammal, Florestan J Koll, Ziyu Chen, et al.
Nature Genetics|February 23, 2016
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancerHikmat A Al-Ahmadie, Gopa Iyer, Byron H Lee, et al.
Der Pathologe|January 5, 2021
[Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference]Oliver Hommerding, Yves Allory, Pedram Argani, et al.
JCO Precision Oncology|June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular PhenotypeNima Almassi, Karissa Whiting, Antoun Toubaji, et al.
Elife|March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinomaJianing Xu, Ed Reznik, Ho-Joon Lee, et al.
Pageof 64

Showing results (601-610 of 633) with videos related to

Sort By:
Pageof 64
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
JAMA Oncology|July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.
The American Journal of Surgical Pathology|October 5, 2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneyLisha Wang, Yuping Zhang, Ying-Bei Chen, et al.
Leukemia|November 9, 2022
Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphomaXi-Ya Li, Ji-Chuan Wu, Ping Liu, et al.
Nature Medicine|June 8, 2010
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanomaNallasivam Palanisamy, Bushra Ateeq, Shanker Kalyana-Sundaram, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2025
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary TractRayan Rammal, Florestan J Koll, Ziyu Chen, et al.
Nature Genetics|February 23, 2016
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancerHikmat A Al-Ahmadie, Gopa Iyer, Byron H Lee, et al.
Der Pathologe|January 5, 2021
[Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference]Oliver Hommerding, Yves Allory, Pedram Argani, et al.
JCO Precision Oncology|June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular PhenotypeNima Almassi, Karissa Whiting, Antoun Toubaji, et al.
Elife|March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinomaJianing Xu, Ed Reznik, Ho-Joon Lee, et al.
Pageof 64